Company Overview
Snapshot
Founded in January 2016 by Yoel Ezra, EFA Technologies operates with 11–50 employees. The company has raised a total of $9.49M across 9 funding rounds from 7 investors. In April 2024, the company received Anvisa approval for its portable RevDx device, enabling its entry into the Brazilian market.
Business overview
EFA Technologies develops the RevDx, an affordable handheld blood test diagnostic tool. This mobile end-point solution performs automatic microscopy tests, including whole blood sampling and automatic diagnosis of blood count. The product is designed for ease of operation, using a finger prick blood sample without requiring laboratory conditions or specific preparations, facilitating real-time informed decisions. RevDx functions as a disease-mapping solution for integrated community case management, serving as a programmable portable lab that aims to automatically diagnose infectious diseases, starting with parasitology and blood cell count, to enable safe, precise, and affordable testing, treating, and tracking. The company operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Digital Healthcare, focusing on Diagnostics Devices and Digital Medical Diagnostics.
Strategic signal
In April 2024, EFA Technologies secured Anvisa approval for its portable RevDx device, marking its entry into the Brazilian market. This regulatory clearance is a significant validation of the device's efficacy and safety, signaling strong potential for market expansion and adoption in Latin America. For investors, this indicates a clear pathway to commercialization and revenue growth in a new, substantial market, reinforcing the company's strategic trajectory in global health diagnostics.
Log in to access full profile ›Company Intelligence Q&A
- What is EFA Technologies' core product?
- EFA Technologies' core product is RevDx, an affordable handheld blood test diagnostic tool that performs automatic microscopy tests, including whole blood sampling and automatic diagnosis of blood count.
- When was EFA Technologies founded and by whom?
- EFA Technologies was founded in January 2016 by Yoel Ezra.
- Which market did EFA Technologies recently enter?
- In April 2024, EFA Technologies entered the Brazilian market following Anvisa approval for its portable RevDx device.
- Which investors participated in EFA Technologies' April 2024 funding round?
- In April 2024, EFA Technologies received funding from Maccabi Healthcare Services and Israel Innovation Authority.
- What was a notable investment in EFA Technologies in December 2018?
- In December 2018, eHealth Ventures and Merchavia Holdings invested in EFA Technologies.